TABLE 4.
Study | Sample size (n) | SNPs | Outcome |
---|---|---|---|
Li, SclRep 2016 (64) | Chinese postmenopausal women (n=1,824} | 4 | BMD: all p >0.1 |
Larsson, JBMR 2018 (60) | 2 cohorts of European descent (n=32,965 and n= 142,487) | 5 linked to 4 vitamin D related genes | 1 SD higher 25(OH)D BMD+ 0.02 CL-0.03 ± 0.07 p >0.1 |
Sun J Cell Mol Med 2019 (58) |
European ancestry (n=61,079) | 6 | total body BMD: p >0.05 at all ages |
Kampe, PlosGen 2019 (61) | Finish children (age 2 yrs; r=761) | 2 | lower 25(OH)D linked to lower BMD p <0.01 |
Ye, GenEpid 2020 (63) | UK Biobark (n=326,409) | 143 | higher 25(OH)D linked to lower risk of leg or femur but not other fractures: OR 0.60 CL 0.45–0.SO |
Colak, Clin Chem 2020 (62) | Danish adults (n=116,335) | 6 | total fracture risk for 3% lower predicted 25(OH)D: OR 0.99 CL 0.981.00 |
Tang, Sci Rep, 2022 (59) | European ancestry (n=67,35S) | 143 | predicted 25(OH)D and BMD at different sites: all p >0.05 |
Abbreviations: SNP: single nucleotide polymorphism, BMD: bone mineral density, NS: non-significant, BMC: bone mineral content